112 related articles for article (PubMed ID: 31028570)
1. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
Lee JH; Lee SW
Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
[TBL] [Abstract][Full Text] [Related]
2. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
[TBL] [Abstract][Full Text] [Related]
3. INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by cellular senescence in colon cancer cells.
Zhang Z; Chen L; Yang Q; Tang X; Li J; Zhang G; Wang Y; Huang H
Int J Biochem Cell Biol; 2024 Jun; 171():106570. PubMed ID: 38588888
[TBL] [Abstract][Full Text] [Related]
4. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
Sakatani A; Sonohara F; Goel A
Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
Blumenthal RD; Osorio L; Hayes MK; Horak ID; Hansen HJ; Goldenberg DM
Cancer Immunol Immunother; 2005 Apr; 54(4):315-27. PubMed ID: 15592930
[TBL] [Abstract][Full Text] [Related]
6. scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells.
Silveira MJ; Martins C; Cruz T; Castro F; Amorim-Costa Â; Chester K; Oliveira MJ; Sarmento B
J Nanobiotechnology; 2023 Oct; 21(1):357. PubMed ID: 37784150
[TBL] [Abstract][Full Text] [Related]
7. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance.
Chen YY; Wang ZX; Chang PA; Li JJ; Pan F; Yang L; Bian ZH; Zou L; He JM; Liang HJ
Cancer Sci; 2009 Sep; 100(9):1708-13. PubMed ID: 19500106
[TBL] [Abstract][Full Text] [Related]
9. The role of p62 in cell death and survival of 5-fluorouracil and oxaliplatin-resistant colorectal cancer cells.
Zitkute V; Jasinevicius A; Vaitiekaite G; Kukcinaviciute E; Aleksandraviciute B; Eidenaite E; Sudeikis L; Jonusiene V; Sasnauskiene A
J Cell Biochem; 2023 Nov; 124(11):1779-1791. PubMed ID: 37842885
[TBL] [Abstract][Full Text] [Related]
10. Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer.
Dong S; Zhang M; Cheng Z; Zhang X; Liang W; Li S; Li L; Xu Q; Song S; Liu Z; Yang G; Zhao X; Tao Z; Liang S; Wang K; Zhang G; Hu S
Redox Biol; 2024 Jul; 73():103207. PubMed ID: 38805974
[TBL] [Abstract][Full Text] [Related]
11. Propolis Enhances 5-Fluorouracil Mediated Antitumor Efficacy and Reduces Side Effects in Colorectal Cancer: An in Vitro and in Vivo Study.
Kocyigit A; Guler EM; Durmus E; Yenigun VB; Kanimdan E; Ozman Z; Yasar O; Goren AC; Hekimoglu ER; Oruc HH; Aydogdu G
Chem Biodivers; 2023 Sep; 20(9):e202300591. PubMed ID: 37497658
[TBL] [Abstract][Full Text] [Related]
12. Broccoli extracellular vesicles enhance the therapeutic effects and restore the chemosensitivity of 5-fluorouracil on colon cancer.
Cao Y; Hou L; Li M; Zhang J; Wang L; Liu C; Luo T; Yan L; Zheng L
Food Chem Toxicol; 2024 Apr; 186():114563. PubMed ID: 38442787
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling.
Anand S; Nedeva C; Chitti SV; Fonseka P; Kang T; Gangoda L; Tabassum NI; Abdirahman S; Arumugam TV; Putoczki TL; Kumar S; Mathivanan S
Cell Death Dis; 2023 Dec; 14(12):828. PubMed ID: 38097550
[TBL] [Abstract][Full Text] [Related]
14. Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer.
Binabaj MM; Asgharzadeh F; Rahmani F; Al-Asady AM; Hashemzehi M; Soleimani A; Avan A; Mehraban S; Ghorbani E; Ryzhikov M; Khazaei M; Hassanian SM
Daru; 2023 Dec; 31(2):193-203. PubMed ID: 37740873
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells.
Li F; Qiu F; Fan X; Yu Q; Liu S; Guo Y; Zhu Y; Xi X; Du B
Gene; 2024 Jan; 892():147896. PubMed ID: 37832805
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer.
Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W
Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742
[TBL] [Abstract][Full Text] [Related]
17. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20.
Fatima I; Ahmad R; Barman S; Gowrikumar S; Pravoverov K; Primeaux M; Fisher KW; Singh AB; Dhawan P
Br J Cancer; 2024 Apr; 130(6):1046-1058. PubMed ID: 38278978
[TBL] [Abstract][Full Text] [Related]
18. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against
Su M; Wen X; Yu Y; Li N; Li X; Qu X; Elsabahy M; Gao H
J Mater Chem B; 2024 Apr; 12(16):3947-3958. PubMed ID: 38586917
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ubiquitin specific peptidase 8 is effective against 5-fluorouracil resistance in colon cancer via suppressing EGFR and EGFR-mediated signaling pathways.
Xi C; Gong Z; Ye H; Cao L; Yu J
Histol Histopathol; 2024 Feb; 39(2):251-261. PubMed ID: 37222451
[TBL] [Abstract][Full Text] [Related]
20. Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance.
Therizols G; Bash-Imam Z; Panthu B; Machon C; Vincent A; Ripoll J; Nait-Slimane S; Chalabi-Dchar M; Gaucherot A; Garcia M; Laforêts F; Marcel V; Boubaker-Vitre J; Monet MA; Bouclier C; Vanbelle C; Souahlia G; Berthel E; Albaret MA; Mertani HC; Prudhomme M; Bertrand M; David A; Saurin JC; Bouvet P; Rivals E; Ohlmann T; Guitton J; Dalla Venezia N; Pannequin J; Catez F; Diaz JJ
Nat Commun; 2022 Jan; 13(1):173. PubMed ID: 35013311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
